• 대한심장학회 KSC
• 대한부정맥학회 KHRS
• 대한소아심장학회 KPHS
• 대한심부전학회 KSHF
• 대한심혈관중재학회 KSIC
• 심장대사증후군학회 KSCMS
• 한국심초음파학회 KSE
• 한국지질∙동맥경화학회 KSoLA

[ACC Together with KSC/KSE 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.300C
ATTR Cardiac Amyloidosis: Not to Be Missed Any More
Chairperson(s)	Ana Barac, Hae Ok Jung
Panel	Darae Kim, Jung-Woo Son
09:35-09:47	Diverse Manifestations of Cardiac Amyloidosis	Hyung Yoon Kim / Chonnam National Univ., Korea
09:47-09:59	Diagnostic Strategies in Clinical Diagnosis	Jordan Ray / Mayo Clinic, USA
09:59-10:11	Use of Imaging to Guide Treatment	Jung Hyun Choi / Pusan National Univ., Korea
10:11-10:20	Discussion

[ACC Together with KSC/KSHF 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.102
Management of Acute Decompensated Heart Failure
Chairperson(s)	Paul Mather, Dong Ju Choi
Panel	Min-Seok Kim
08:40-08:55	Hemodynamic Assessment	Paul Mather / Univ. of Pennsylvania, USA
08:55-09:02	Discussion
09:02-09:17	Inotropic Support and Transition to Oral Medications	Michael Genuardi / Univ. of Pennsylvania, USA
09:17-09:24	Discussion

[ACC Together with KSC/KSHF 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.102
New Heart Failure Therapies
Chairperson(s)	Paul Mather, Seok Min Kang
09:35-09:50	How and When to Initiate 4-Pillar Therapy?	Hyun-Jai Cho / Seoul National Univ., Korea
09:50-09:57	Discussion
09:57-10:12	The Role of SGLT2 Inhibitors and ARNI’s in the Management of Heart Failure: Tips From the Experts	Michael Genuardi / Univ. of Pennsylvania, USA
10:12-10:20	Discussion

[ACC Together with KSC/KSE 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.300C
Myocarditis: Learning from Our Diverse Clinical Experience
Chairperson(s)	Y.S. Chandrashekhar, Sangchol Lee
Panel	Hyun-Jung Lee, Jae Yeong Cho
08:40-08:50	Case: COVID and Myocarditis	In-Cheol Kim / Keimyung Univ., Korea
08:50-09:00	Case: Inflammatory Disease Affecting the Heart	Leslie Cooper / Mayo Clinic, USA
09:00-09:10	Case: Cancer Treatment and Myocarditis	Ana Barac / Georgetown Univ., USA
09:10-09:25	Discussion

[ACC Together with KSC/KHRS 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.103
Is Rate Control Dead?
Chairperson(s)	Fred Kusumoto, Hui Nam Pak
Panel	Changsheng Ma, Jong Sung Park
08:40-08:50	Patient Selection for Rate Control	Litsa Lambrakos / Univ. of Miami Health System, USA
08:50-09:00	Pharmacologic Strategies for Rate Control	Eue-Keun Choi / Seoul National Univ., Korea
09:00-09:10	Role of AVN Ablation in 2022: Benefits and Consequences	Kenneth Bilchick / Univ. of Virginia, USA
09:10-09:25	Discussion

[ACC Together with KSC/KHRS 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.103
Sudden Death: ICDs and?
Chairperson(s)	Rungroj Krittayaphong, Gi Byoung Nam
Panel	Freddy Del-Carpio Munoz, Namsik Yoon
09:35-09:45	Nondevice Therapies and SCD Prevention	Jong-Il Choi / Korea Univ., Korea
09:45-09:55	ICDs in NICM: Who and When	Dan Sorajja / Mayo Clinic, USA
09:55-10:05	ICDs in Channelopathies and HCM	Martin Maron / Tufts Medical Center, USA
10:05-10:20	Discussion

[Basic Research Hot Session 1]		Apr. 15 (Fri.) 08:40-10:20 Rm.105
Regeneration of Cardiac Tissue
Chairperson(s)	Hyo-Soo Kim, Yong Kun Kwon
Panel	Sung Ha Park, Kiyuk Chang, Woochul Chang , Jung-Kyu Han
08:40-09:00	Regeneration of Infarcted Mouse Hearts by Cardiovascular Tissue Formed via the Direct Reprogramming of Mouse Fibroblasts	Young Sup Yoon / Emory Univ., Korea
09:00-09:20	Human iPSC-based Cardiac Microphysiological System for Disease Modeling and Space Biology	Deok-Ho Kim / Johns Hopkins Univ., USA
09:20-09:40	Mussel-Derived Adhesive Protein as an Innovative Functional Biomaterial for Effective Cardiac Tissue Regeneration	Hyung Joon Cha / POSTECH, Korea
09:40-10:00	In vivo Therapeutic Genome Editing via CRISPR/Cas9 Magnetoplexes for Myocardial Infarction	Jongpil Kim / Dongkuk University, Korea
10:00-10:10	Discussion

[Women Heart Disease]		Apr. 15 (Fri.) 08:40-10:20 Rm.203
Pregnancy Associated Cardiovascular Risk
Chairperson(s)	Kyung-Soon Hong, Myung A Kim
Panel	Mi Na Kim, Sang Min Park, Young Sup Byun
08:40-08:58	Pregnancy Number and Cardiovascular Risk	Hack Lyoung Kim / Seoul National Univ., Korea
08:58-09:16	Preeclampsia and Long-term Cardiovascular Disease	홍기림 / Cha Univ., Korea
09:16-09:34	Peripartum Cardiomyopathy in Korea	Jin Oh Na / Korea Univ., Korea
09:34-09:52	Cardiovascular Imagings and Tests in Pregnant Women	Hyun-Jin Kim / Hanyang Univ., Korea
09:52-10:10	Discussion

[ACHD 1]		Apr. 15 (Fri.) 08:40-09:25 Rm.205
Belated Diagnosis of PDA in Adult with CHD
Chairperson(s)	I Seok Kang
Panel	Woong Chol Kang, Byoung Kwon Lee
08:40-08:52	What to Do for Small PDA in ACHD	Jae-Hyeong Park / Chungnam National Univ., Korea
08:52-09:04	What to Do for Large PDA in ACHD	Jinyoung Song / Sungkyunkwan Univ., Korea
09:04-09:16	Severe Pulmonary Hypertension with PDA in ACHD	Kyung-Hee Kim / Incheon Sejong Hospital, Korea
09:16-09:25	Discussion

[ACHD 2]		Apr. 15 (Fri.) 09:35-10:20 Rm.205
Where Are We Now in Pulmonary Valve Implantation
Chairperson(s)	Hyoung Doo Lee
Panel	Hun Go, So Ick Jang
09:35-09:47	Update for PPVI with PULSTA	Gi Beom Kim / Seoul National Univ., Korea
09:47-09:59	Echocardiographic Imaging Assessment before PPVI	Seulgi Cha / Ulsan Univ., Korea
09:59-10:11	Cardiac Rehabilitation in ACHD	Lucy Youngmin Eun / Yonsei Univ., Korea
10:11-10:20	Discussion

[ACC Together with KSC (Imaging)]		Apr. 15 (Fri.) 10:30-11:15 Rm.300C
Chest Pain Guidelines from Cardiovascular Imaging Perspective
Chairperson(s)	Aaron Kugelmass, Andy Wai Khong Chan
10:30-10:40	Cardiac CT Imaging	Sumbal Janjua / MedStar Washington Hospital Centre, USA
10:40-10:50	CMR	Eui-Young Choi / Yonsei Univ., Korea
10:50-11:00	Nuclear Imaging	Prem Soman / Univ. of Pittsburgh, USA
11:00-11:10	Echocardiography	Judy Hung / Harvard Medical School, USA
11:10-11:15	Discussion

[ACC Together with KSC/KSoLA]		Apr. 15 (Fri.) 11:25-12:10 Rm.300C
Optimization of Cardiovascular Risk Factors to Prevent ASCVD in Specific Populations
Chairperson(s)	Nathan Wong, Soon Jun Hong
Panel	Anwar Santoso, Ung Kim
11:25-11:35	Optimization of CV Risk Factors for Women	Erin Michos / Johns Hopkins Univ. , USA
11:35-11:45	CV Risk Factor Optimization for Older Persons: Current Gaps and Future Directions	Noreen Nazir / Univ. of Illinois, USA
11:45-11:55	CV Risk Factor Optimization for Asians	Jung Ho Heo / Kosin Univ., Korea
11:55-12:10	Discussion

[ACC Together with KSC/KSIC 1]		Apr. 15 (Fri.) 10:30-11:15 Rm.102
Asymptomatic Severe AS
Chairperson(s)	Harold Dauerman, Hyo-Soo Kim
Panel	Duk Woo Park, Sung Ji Park, Sak Lee
10:30-10:42	What Do Guidelines Say for When to Intervene for Asymptomatic AS?	Kian Keong Poh / National Univ. of Singapore, Singapore
10:42-10:54	AVATAR and RECOVERY Trials: Should We Be Intervening Earlier?	Michael Rinaldi / Sanger Heart & Vascular Institute, USA
10:54-11:06	When To Do SAVR vs. TAVR for Severe AS	Peter Pollak / Mayo Clinic, USA
11:06-11:15	Discussion

[ACC Together with KSC/KSIC 2]		Apr. 15 (Fri.) 11:25-12:10 Rm.102
Challenging Valvular Cases
Chairperson(s)	Kian Keong Poh, Myeong Ki Hong
Panel	Jung-Sun Kim, Kiyuk Chang, Geu-Ru Hong
11:25-11:35	Case: Severe AS and Severe Calcific MS: What to Do with Mitral Valve When Intervening for AS?	Abdallah El Sabbagh / Mayo Clinic, USA
11:35-11:40	Discussion
11:40-11:50	The Pivot-TR Preclinical Data: How Easy Can a TR Device Go for The Procedure?	June Hong Kim / Pusan National Univ., Korea
11:50-11:55	Discussion
11:55-12:05	Case: 58 Year Old Male with BAV, Asymptomatic Severe AS (Peak and Mean 120/70 mmHg): What Type of Valve?	Molly Szerlip / Baylor Scott and White The Heart Hospital Plano, USA
12:05-12:10	Discussion

[ACC Together with KSC/KHRS 3]		Apr. 15 (Fri.) 10:30-11:15 Rm.103
Atrial Fibrillation Ablation: Who and When?
Chairperson(s)	Fred Kusumoto, Kee-Joon Choi
Panel	Hyoung-Seob Park
10:30-10:40	AFFIRM vs. EAST AFNet4: Why the Difference?	Boyoung Joung / Yonsei Univ., Korea
10:40-10:50	How Do I Select Heart Failure Patients to Refer to EP for Ablation?	Juan Carlos Leoni / Mayo Clinic, USA
10:50-11:00	What to Do After the First AF Ablation Fails?	Nassir Marrouche / Tulane Univ., USA
11:00-11:15	Discussion

[ACC Together with KSC (Myocardial Infarction)]		Apr. 15 (Fri.) 11:25-12:10 Rm.103
Emerging Trends in STEMI Care
Chairperson(s)	Aaron Kugelmass, Myung Ho Jeong
Panel	Junbo Ge
11:25-11:30	Intro
11:30-11:42	Emerging Issues and Therapies for STEMI in US	Kwan Lee / Univ. of Arizona, USA
11:42-11:54	Emerging Issues and Therapies for STEMI in Korea	Jang Hoon Lee / Kyungpook National Univ., Korea
11:54-12:10	Discussion

[Basic Research Hot Session 2]		Apr. 15 (Fri.) 10:30-12:10 Rm.105
Current Trends of Cardiovascular Research
Chairperson(s)	Kim Chi Dae, Dong Hoon Choi
Panel	Hyun Kook, Yoo-Wook Kwon, Sun Sik Bae
10:30-10:55	DII4 Suppresses Transcytosis for Arterial Blood-retinal Barrier Homeostasis	In-June Kim / KAIST, Korea
10:55-11:20	Application of Prime Editing to the Correction of Mutations and Phenotypes in Vascular Disease	Dong Hyun Jo / Seoul National Univ., Korea
11:20-11:45	S-Nitrosylation of Histone Deacetylase 2 by Neuronal Nitric Oxide Synthase as a Mechanism of Diastolic Dysfunction	Somy Yoon / Chonnam National University, Korea
11:45-12:00	Discussion

[Cardiogenic Shock]		Apr. 15 (Fri.) 10:30-11:15 Rm.203
Optimal Care in Patients with ECMO in Cardiogenic Shock
Chairperson(s)	Hyeon-Cheol Gwon, Seok Min Kang
Panel	Jin Jin Kim, Jaewon Oh, Hyun-Jai Cho, Ki Hong Choi
10:30-10:45	Optimal Management and Monitoring during ECMO in Patients with Cardiogenic Shock	Jae-Seung Jung / Korea Univ., Korea
10:45-11:00	Optimal ECMO Weaning and Post-ECMO Care in Patients with Cardiogenic Shock	Jeong Hoon Yang / Sungkyunkwan Univ., Korea
11:00-11:15	Discussion

[Imaging]		Apr. 15 (Fri.) 11:25-12:10 Rm.203
Post-Ischemia Trial Era: Role Of Cardiac Imaging
Chairperson(s)	Hee Seung BOM, Byoung Wook Choi
Panel	Dong Hyun Yang, Jin Chul Paeng
11:25-11:35	Clinical Practice in Post-Ischemia Trial Era	Sung Jin Hong / Yonsei Univ., Korea
11:35-11:45	Role of CT Angiography (CT Perfusion)
11:45-11:55	Role of Cardiac MRI	Sung-A Chang / Sungkyunkwan Univ., Korea
11:55-12:05	Role of Nuclear Cardiac Imaging	Joon-Young Choi / Sungkyunkwan Univ., Korea
12:05-12:10	Discussion

[ACHD 3]		Apr. 15 (Fri.) 10:30-11:15 Rm.205
Extracardiac Problems in ACHD: We Need More Concerns
Chairperson(s)	Seung Woo Park
Panel	Sung-A Chang, Eun-Young Choi
10:30-10:42	Abnormal Lung Function in Adults with Congenital Heart Disease	Hyun Lee / Hanyang Univ., Korea
10:42-10:54	Hepatopathy in Adult with Congenital Heart Disease	Sang Yun Lee / Seoul National Univ., Korea
10:54-11:06	Systemic Illness in Adult with Cyanotic Congenital Heart Disease	Min Sun Kim / Sungkyunkwan Univ., Korea
11:06-11:15	Discussion

[ACHD 4]		Apr. 15 (Fri.) 11:25-12:10 Rm.205
Long Term Prognosis of Complex Congenital Heart Disease
Chairperson(s)	June Huh
Panel	Hyun Ju Yoon
11:25-11:37	Arterial Switch Operation	Jae Gun Kwak / Seoul National Univ., Korea
11:37-11:49	Ross Procedure	Chun Soo Park / Ulsan Univ., Korea
11:49-12:01	Fontan Operation	Ji-Hyuk Yang / Sungkyunkwan Univ., Korea
12:01-12:10	Discussion

[Diamond Session [Amgen]]		Apr. 15 (Fri.) 12:20-13:00 Rm.300C
LDL-C Management: From Hospitalization to Discharge in ACS Patients
Chairperson(s)	Myung Ho Jeong, Hun Sik Park
Panel	Joon Ho Ahn,
12:20-12:35	LDL-C Lowering Strategies in ACS Patients from Hospitalization	Youngwoo Jang / Gachon Univ., Korea
12:35-12:50	Case Review: How to Use Evolocumab in My Practice	Byung Jin Kim / Sungkyunkwan Univ., Korea
12:50-13:00	Discussion

[Diamond Session [Viatris]]		Apr. 15 (Fri.) 12:20-13:00 Rm.102
Lipitor Portfolio, Optimal Treatment for ACS Patients
Chairperson(s)	Bon-Kwon Koo
12:20-12:40	Early Bird of High Intensity Statin to Close the Gap between Theory and Practice in ACS Patients
12:40-13:00	When and Why Combination Therapy Is Needed for Dyslipidemia Patients? As the Next Option of Maximum Tolerable Mono Statin Therapy	Jung-Woo Son / Yonsei Wonju Univ., Korea

[Scientific Session [Pfizer/BMS]]		Apr. 15 (Fri.) 12:20-13:00 Rm.103
Better Patient Care with Anticoagulation in AF and VTE
Chairperson(s)	Doo Il Kim, Seil Oh
12:20-12:40	Anticoagulation Strategy for Elderly AF Patients with Comorbidities: Suggestion from Eliquis	So-Ryoung Lee / Seoul National Univ., Korea
12:40-13:00	Anticoagulation Strategy for VTE Patients: Suggestion from Eliquis	Jaewon Oh / Yonsei Univ., Korea

[Scientific Session [Boryung]]		Apr. 15 (Fri.) 12:20-13:00 Rm.105
New Insights in the Treatment of Hypertension
Chairperson(s)	Duk-Hyun Kang, Jong-Won Ha
12:20-12:40	Achieving Target Blood Pressure with Triple-combination Therapy, Dukarb Plus	Young Joon Hong / Chonnam National Univ., Korea
12:40-13:00	New Clinical Outcome of Fimasartan in Korean Hypertensive Patients	Chan Joo Lee / Yonsei Univ., Korea

[Scientific Session [Samjin] ]		Apr. 15 (Fri.) 12:20-13:00 Rm.203
Updates on Treatment Strategies for High-risk Patients
Chairperson(s)	Seong Ill WOO, In-Ho Chae
12:20-12:35	Review of HOST-EXAM: What Is Optimal Antiplatelet Therapy after DAPT for Undergoing PCI Patients?	Jee Hoon Kang / Seoul National Univ., Korea
12:35-12:50	Managing AF Patient Undergoing PCI: Focused on Rivaroxaban	Young-Hoon Jeong / Chung-Ang Univ., Korea
12:50-13:00	Discussion

[Scientific Session [Organon] ]		Apr. 15 (Fri.) 12:20-13:00 Rm.205
Early & Lower for Longer Through Intensity Statin and Ezetimibe for Lipid Management
Chairperson(s)	Seung-Ho Hur
12:20-12:35	Early for Longer: Intensive Lipid Lowering - Moving beyond Statins Alone	Dae-Hee Kim / Ulsan Univ., Korea
12:35-12:50	Lower for Longer: Effective Lipid Lowering - Rising on Ezetimibe Therapy	Young Bin Song / Sungkyunkwan Univ., Korea
12:50-13:00	Discussion

[Memorial Lecture]		Apr. 15 (Fri.) 13:10-13:50 Rm.300C
Chairperson(s)	Eugene Yang, Hyo-Soo Kim
13:10-13:25	故 이성호 교수님 회고	Byung-Hee Oh / Incheon Sejong Hospital, Korea
13:25-13:50	Cardiovascular Innovations/Future Talk	Ami Bhatt / Harvard Medical School, USA

[Scientific Session [Novartis]]		Apr. 15 (Fri.) 13:10-13:50 Rm.102
ARNI: 1st Choice for below Normal LVEF Heart Failure Patients
Chairperson(s)	Yong Seog Oh, Seok Min Kang
13:10-13:30	Expanding Role of Entresto for HF with below Normal EF	Gregg C. Fonarow / Ronald Reagan UCLA Medical Center, USA
13:30-13:50	Evolving Role of Entresto as First Choice for Your HF Patient	Hyun-Jai Cho / Seoul National Univ., Korea

[Scientific Session [Boehringer Ingelheim/Lilly]]		Apr. 15 (Fri.) 13:10-13:50 Rm.103
SGLT2 Inhibition in HFrEF; Digging Deeper and Treating Earlier
Chairperson(s)	Myeong Ki Hong, Byung Su Yoo
13:10-13:30	Quantum Leaps with Empagliflozin from T2D to HFrEF	Jon Suh / Soonchunhyang Univ., Korea
13:30-13:50	Empagliflozin as An Early, First Line Therapy in Patients with HFrEF	Jae Yeong Cho / Chonnam National Univ., Korea

[Scientific Session [Bayer]]		Apr. 15 (Fri.) 13:10-13:50 Rm.105
Heart and Brain in High-Risk Vascular Disease Patients. Let`s Complete the Puzzle!
Chairperson(s)	Moon-Hyoung Lee, Seung-Woon Rha
13:10-13:30	How to Protect Vascular Events in NVAF Patients with DM	Eue-Keun Choi / Seoul National Univ., Korea
13:30-13:50	How to Protect Patients with Poly-vascular Disease	Byeong-Keuk Kim / Yonsei Univ., Korea

[Scientific Session [Celltrion Pharm/Dong-A ST]]		Apr. 15 (Fri.) 13:10-13:50 Rm.203
Benefits of Intensive & Consistent BP Control for Reducing CVD Risk
Chairperson(s)	Dong Ju Choi, Kee-Joon Choi
13:10-13:30	Importance of 24h BP Control for Reducing CVD Risk; The Role of Edarbi	Jung Hyun Choi / Pusan National Univ., Korea
13:30-13:50	Intensive Treatment Strategy in Hypertension	JI Young Park / Eulji Univ., Korea

[Insurance Issues]		Apr. 15 (Fri.) 14:00-15:30 Rm.300C
3차 상대가치 조정과 시술 영역의 신설
Chairperson(s)	Dong Jin Oh, Jang-Whan Bae
Panel	Jin-Bae Kim, Jon Suh, Seonghoon Choi
14:00-14:15	내소정 입원 진료료 가산 관련 문제점 - 3차 상대가치 기본진료료 개편 방안	Byung Ok Kim / Inje Univ., Korea
14:15-14:30	3차 상대가치 조정-영상 검체검사 가산 삭제의 문제점과 개선방향	Deok Kyu Cho / Yonsei Univ., Korea
14:30-14:45	Discussion
14:45-15:00	심혈관계 시술을 인터벤션 영역으로의 독립-의협의 입장
15:00-15:15	심혈관계 시술을 인터벤션 영역으로의 독립-정부의 입장
15:15-15:30	Discussion

[Myocardial Infarction 1]		Apr. 15 (Fri.) 14:55-15:40 Rm.105
Tough Calls during AMI PCI
Chairperson(s)	Hun Sik Park, Kwang Soo Cha
Panel	Jeongsu Kim, Kyeong Ho Yun, Chang Hwan Yoon, Sang Yeub Lee
14:55-15:07	How to Find Culprit Lesion and Manage Non-Culprit Lesion: Imaging and Physiology	Hyun Kuk Kim / Chosun Univ., Korea
15:07-15:19	How to Overcome Coronary Thrombosis during Primary PCI	Young Jin Youn / Yonsei Wonju Univ., Korea
15:19-15:31	Which Is the First Strategy in AMI with Cardiogenic Shock: VA-ECMO or PCI?	Woo Jin Jang / Ewha Univ., Korea
15:31-15:40	Discussion

[Smart Health]		Apr. 15 (Fri.) 14:00-14:45 Rm.203
How to Use Wearable Devices?
Chairperson(s)	Seung Woo Park, Sung Ha Park
Panel	Sung-Hwan Kim, Jaemin Shim
14:00-14:10	How to Set Up ECG Patch Devices in My Hospital?	Young Jin Cho / Seoul National Univ., Korea
14:10-14:20	Can I Use a Smart Watch or a Ring-type Device in My Clinic?	Jun Kim / Ulsan Univ., Korea
14:20-14:30	Clinical Use of a Life-style ECG Device	Joon-Myoung Kwon / Incheon Sejong Hospital, Korea
14:30-14:45	Discussion

[Basic Research 1]		Apr. 15 (Fri.) 14:00-15:30 Rm.205
How to Perform Good Cardiovascular Basic and Translational Research?
Chairperson(s)	Goo Taeg Oh, Pil-Ki Min
Panel	Yoo-Wook Kwon, Yong Sook Kim, Sang-Hak Lee, Sang Hyun Ihm
14:00-14:20	심장 기초중개 연구 국책과제 연구비를 수주하기 위한 노하우	Hun-Jun Park / Catholic Univ., Korea
14:20-14:40	좋은 심장 기초중개 연구를 위한 노하우 - 기초의과학자 입장	Hyoung Kyu Kim / Inje Univ., Korea
14:40-15:00	좋은 심장 기초중개 연구를 위한 노하우 - 임상의사 입장	Jaewon Oh / Yonsei Univ., Korea
15:00-15:20	How Big Data Changes the Biomedical Research?	Hyun-Young Park / NIH
15:20-15:30	Discussion

[Healthcare Policy]		Apr. 15 (Fri.) 15:50-17:20 Rm.300C
심장내과 분과전문의 수급에 대한 현안과 대책
Chairperson(s)	Joong Wha Chung, Sung-Hwan Kim
Panel	Se Eun Kim, Jin Oh Na, Tae Ho Park, Jin-A Choi
15:50-16:10	심장내과 의료인력 현황과 문제점	Sung Kee Ryu / Eulji Univ., Korea
16:10-16:30	학문후속세대 감소의 원인	Jin-Bae Kim / Kyunghee Univ., Korea
16:30-16:50	학문후속세대 감소의 대책	Song-Yi Kim / Jeju National Univ., Korea
16:50-17:20	Discussion

[Myocardial Infarction 2]		Apr. 15 (Fri.) 15:50-16:35 Rm.105
Controversial Issues for the Treatment of AMI
Chairperson(s)	Myung Ho Jeong, Jin Yong Hwang
Panel	Byeong-Keuk Kim, Jang-Whan Bae, Jang Hoon Lee, Yong Whan LIM
15:50-16:05	Shortening DAPT Duration for AMI: Is It Safe or Not?	Joo-Yong Hahn / Sungkyunkwan Univ., Korea
16:05-16:20	Lowering LDL As Possible As You Can: Is It Working or Not?	Weon Kim / Kyunghee Univ., Korea
16:20-16:35	Discussion
16:35-16:50	Complete Revascularization for AMI Complicating Cardiogenic Shock: In the Case of MCS	Min Chul Kim / Chonnam National Univ., Korea
16:50-17:05	Novel Pharmacotherapy for HF after AMI: SGLT2, ARNI - Initial Strategy vs. Last Resort?	Sang Rok Lee / Jeonbuk National Univ., Korea
17:05-17:20	Discussion

[Epidemiology]		Apr. 15 (Fri.) 15:50-16:35 Rm.203
CVD Epidemiology Study Using National Health Insurance Big Data
Chairperson(s)	Hyeon Chang Kim, Jong-Il Choi
15:50-16:00	Hypertension and CVD Risk	Hokyou Lee / Yonsei Univ., Korea
16:00-16:10	CVD Risk in Cancer Survivors	Jong-Chan Youn / Catholic Univ., Korea
16:10-16:20	Prevention and Prognosis of Atrial Fibrillation	So-Ryoung Lee / Seoul National Univ., Korea
16:20-16:30	Lifestyle Risk Factors of CVD	Dong Wook Shin / Sungkyunkwan Univ., Korea
16:30-16:35	Discussion

[Basic Research 2]		Apr. 15 (Fri.) 15:50-17:20 Rm.205
How to Make IHD and HF Model for Basic and Translational Cardiovascular Research?
Chairperson(s)	Youngkeun Ahn, Jin Han
Panel	Sun Hee Woo, Sung Woo Cho, Hyung Joon Joo, Seung Hwan Han
15:50-16:10	Murine and Rodent Model	Seung-Jun Lee / Yonsei Univ., Korea
16:10-16:30	Pig Model
16:30-16:50	In Vitro Model: Cell Line and Patient Specific iPSC-derived Cardiovascular Cell	Han-Mo Yang / Seoul National Univ., Korea
16:50-17:10	Electrophysiology and Echocardiography Evaluation in Animal Model
17:10-17:20	Discussion

[ACC Together with KSC (Education Workshop 1)]		Apr. 16 (Sat.) 08:00-08:45 Rm.300C
Wide Complex Tachycardia
Chairperson(s)	Zachary Goldberger, Young-Hoon Kim
Panel	Hean Yee Ong, Jaemin Shim, Sung-Won Jang
08:00-08:15	Lecture	Fred Kusumoto / Mayo Clinic, USA
08:15-08:45	ECG Examples	Fred Kusumoto / Mayo Clinic, USA

[ACC Together with KSC (Education Workshop 2)]		Apr. 16 (Sat.) 08:55-09:40 Rm.300C
Contemporary Approaches to Stable Ischemic Heart Disease
Chairperson(s)	Yuk-Kong Lau, Bon-Kwon Koo
Panel	Junbo Ge, Alan Yean Yip Fong , Young Joon Hong
08:55-09:10	Evaluation/Diagnosis of Stable Ischemic Heart Disease	Jung-Min Ahn / Ulsan Univ., Korea
09:10-09:25	Treatment Paradigms	Kwan Lee / Univ. of Arizona, USA
09:25-09:40	Discussion

[ACC Together with KSC/KSE 3]		Apr. 16 (Sat.) 08:00-08:45 Rm.102
The Tricuspid Valve: Forgotten No More
Chairperson(s)	Harold Dauerman, Jong-Won Ha
Panel	Sung Hee Shin, Iksung Cho
08:00-08:12	How to Assess the Prognosis of TR	Jun-Bean Park / Seoul National Univ., Korea
08:12-08:24	Imaging of the TV, Echocardiography and More	Jin Sun Park / Ajou Univ., Korea
08:24-08:36	Overview of Percutaneous TV Devices	Tsuyoshi Kaneko / Brigham and Women’s Hospital, USA
08:36-08:45	Discussion

[ACC Together with KSC/KSE 4]		Apr. 16 (Sat.) 08:55-09:40 Rm.102
CV Imaging in Heart Failure: How and When to Use Echo, CMR and CT?
Chairperson(s)	Ana Barac, Sang Hong Baek
Panel	Hean Yee Ong, Jin Oh Choi
08:55-09:05	Role of Echocardiography	David Dudzinski / Massachusetts General Hospital, USA
09:05-09:15	Role of CMR	Yeonyee E. Yoon / Seoul National Univ., Korea
09:15-09:25	Role of CT	Sang Eun Lee / Ewha Univ., Korea
09:25-09:40	Discussion

[ACC Together with KSC/KSHF 3]		Apr. 16 (Sat.) 08:00-08:45 Rm.103
Innovations in Heart Transplantation: What Does the Future Hold?
Chairperson(s)	Biykem Bozkurt
08:00-08:15	Heart Transplant Rejection Surveillance: Is It Time to Put Away Our Bioptomes?	Paul Mather / Univ. of Pennsylvania, USA
08:15-08:22	Discussion
08:22-08:37	Innovative Immunosuppressive Strategies: Improving Tolerance and Minimizing Side Effects	Kyung-Hee Kim / Incheon Sejong Hospital, Korea
08:37-08:45	Discussion

[ACC Together with KSC/KSHF 4]		Apr. 16 (Sat.) 08:55-09:40 Rm.103
HFpEF: Guidelines, Therapies, and Non-Pharmalogical Approaches
Chairperson(s)	Paul Mather, Byung Su Yoo
08:55-09:05	HFpEF in the Eyes of the European and U.S. Guidelines	Stuart Prenner / Univ. of Pennsylvania, USA
09:05-09:10	Discussion
09:10-09:20	Therapies for HFpEF: The Impact of SGLT2 Inhibitors and ARNI’s on the Disease Process	Jaewon Oh / Yonsei Univ., Korea
09:20-09:25	Discussion
09:25-09:35	Non-Pharmacological Approaches to Improving Symptoms and Exercise Capacity	Jagmeet Singh / Harvard Medical School, USA
09:35-09:40	Discussion

[ACC Together with KSC (Smart Health)]		Apr. 16 (Sat.) 08:00-08:45 Rm.105
Leveraging Technology for CV Prevention
Chairperson(s)	Nannette Rey, Yong-Jin Kim
Panel	Chang Hwan Yoon, Jong-Il Choi
08:00-08:10	Wearable Devices: Friend or Foe?	Il-Young Oh / Seoul National Univ., Korea
08:10-08:20	Remote Blood Pressure Monitoring: Does It Work?	Joseph Ebinger / Cedars-Sinai Medical Center, USA
08:20-08:30	Future Technologies for CV Prevention: Where Are We Headed?	Jun Beom Park / Ewha Univ., Korea
08:30-08:45	Discussion

[ACC Together with KSC/KSCMS]		Apr. 16 (Sat.) 08:55-09:40 Rm.105
Beyond LDL-C Lowering: Role of Non-Statin Therapies
Chairperson(s)	Eugenia Gianos, Kwang Kon Koh
Panel	Orlando Bugarin, Sang-Ho Jo
08:55-09:10	Overview of Non-Statin Therapies	Pamela Morris / Univ. of South Carolina, USA
09:10-09:15	Case: Fibrates	Jae Bin Seo / Seoul National Univ., Korea
09:15-09:20	Discussion
09:20-09:25	Case: Fish Oil, Icosapent Ethyl	Hyun-Jin Kim / Hanyang Univ., Korea
09:25-09:30	Discussion
09:30-09:35	Case: PCSK9 Inhibitors	Youngwoo Jang / Gachon Univ., Korea
09:35-09:40	Discussion

[Journal of the American College of Cardiology (JACC) Asia: Pulmonary Vascular Medicine]		Apr. 16 (Sat.) 08:00-08:45 Rm.205
Chairperson(s)	Zhi-Cheng Jing, Lewis J. Rubin
Panel	Keiko Takihara, Irene M. Lang, You-Yang Zhao, Wook-Jin Chung
08:00-08:02	Opening Remarks	Lewis J. Rubin / Columbia Univ. , USA
08:02-08:06	Pulmonary Vascular Disease Is also an Important Field Focused on by JACC: Asia	Jian-An Wang / Zhejiang Univ., China
08:06-08:13	Anatomy, Classification and Interventional Treatment of Pulmonary Vein Stenosis	Yun-Shan Cao / Gansu Provincial Hospital, China
08:13-08:20	PHOENIKS Platform, A Longitudinal PH Cohort Platform with Biobank for Multi-omics in Korea	Kyung Jin Ahn / Gachon Univ., Korea
08:20-08:27	Genetic Assessment for PAH: Challenging for the Precision Medicine in Asia	Takahiro Hiraide / Keio Univ., Japan
08:27-08:29	Discussion
08:29-08:33	Overview of the Publications on Pulmonary Vascular Diseases in JACC: Asia	Zong-Ye Cai / Zhejiang Univ., China
08:33-08:37	Case: Percutaneous Transluminal Pulmonary Angioplasty for a Patient with Takayasu’s Arteritis and Pulmonary Hypertension	Yu-Ping Zhou / Peking Union Medical College Hospital, China
08:37-08:41	Case: A PAH Case Associated with Qin-Dai (Induribin)	Fusako Sera / Osaka Univ., Japan
08:41-08:43	Discussion
08:43-08:45	Closing Remarks	Zhi-Cheng Jing / Peking Union Medical College Hospital, China

[ACC Together with KSC (Education Workshop 3)]		Apr. 16 (Sat.) 09:50-10:35 Rm.300C
Universal Definition of Heart Failure and the Impact on Your Practice
Chairperson(s)	Paul Mather, Seok Min Kang
Panel	Wook-Jin Chung, Jin Oh Choi
09:50-10:05	What Is New in the Universal Definition of Heart Failure? Summary and Implications	Biykem Bozkurt / Baylor College of Medicine, USA
10:05-10:20	How Will the New Definition and Staging Impact Practice and Care?	Kye Hun Kim / Chonnam National Univ., Korea
10:20-10:35	Discussion

[ACC Together with KSC (Education Workshop 4)]		Apr. 16 (Sat.) 10:45-11:30 Rm.300C
Latest in Valvular Heart Disease Management: 2020 ACC/AHA Valvular Heart Disease Guidelines Update
Chairperson(s)	Edgar Tay , Duk-Hyun Kang
Panel	Dae-Hee Kim, Seung Pyo Lee
10:45-11:02	Update on Aortic Stenosis and Regurgitation	Y.S. Chandrashekhar / Univ. of Minnesota, USA
11:02-11:19	Update on MR/MS	Katy Lease Lonergan / UT Southwestern Medical Center, USA
11:19-11:30	Discussion

[ACC Together with KSC (Hypertension)]		Apr. 16 (Sat.) 09:50-10:35 Rm.102
Hypertension Management in Older Persons: Intensive vs. Standard Treatment
Chairperson(s)	Gilbert Vilela, Sang Hyun Ihm
09:50-09:52	Pre-debate Audience Poll
09:52-10:02	Hypertension in Older Persons: Yes to Intensive Treatment	Seamus Whelton / Johns Hopkins Ciccarone Center,USA
10:02-10:12	Hypertension in Older Persons: No to Intensive Treatment	Kwang-il Kim / Seoul National Univ., Korea
10:12-10:15	Pro Rebuttal	Seamus Whelton / Johns Hopkins Ciccarone Center,USA
10:15-10:18	Con Rebuttal	Kwang-il Kim / Seoul National Univ., Korea
10:18-10:33	Post-debate Poll and Discussion

[ACC Together with KSC (Epidemiology)]		Apr. 16 (Sat.) 10:45-11:30 Rm.102
Cardiovascular Risk Assessment for Koreans: Opportunities for Improvement
Chairperson(s)	Laurence Sperling, Sang-Hyun Kim
10:45-10:50	Case: Current Korean CV Risk Assessment	Hyung Joon Joo / Korea Univ., Korea
10:50-11:00	ACC Pooled Cohort Equation: Does It Apply to Koreans?	Eugene Yang / Univ. of Washington, USA
11:00-11:10	CV Risk Assessment for Koreans: What Tools to Use	Hyeon Chang Kim / Yonsei Univ., Korea
11:10-11:20	Korean CV Risk Assessment: New Risk Calculators	Hokyou Lee / Yonsei Univ., Korea
11:20-11:30	Discussion

[ACC Together with KSC (Cardiogenic Shock)]		Apr. 16 (Sat.) 09:50-10:35 Rm.103
Advances in Cardiogenic Shock
Chairperson(s)	Aaron Kugelmass, Hyeon-Cheol Gwon
Panel	In-Cheol Kim, Chul-Min Ahn, Jeong Hoon Yang, Jae-Seung Jung
09:50-09:55	Intro
09:55-10:05	Learnings from Korean Cardiogenic Shock Study (RESCUE Registry)	Ki Hong Choi / Sungkyunkwan Univ., Korea
10:05-10:15	Diagnostic and Risk Stratification in Cardiogenic Shock	Min-Seok Kim / Ulsan Univ., Korea
10:15-10:25	Recent Update in Mechanical Circulatory Support in Cardiogenic Shock	Isman Firdaus / Harapan Kita Hospital, Indonesia
10:25-10:35	Discussion

[ACC Together with KSC (Vascular)]		Apr. 16 (Sat.) 10:45-11:30 Rm.103
Role of Cardiac Rehabilitation for CV Prevention
Chairperson(s)	Richard Josephson, Ki Chul Sung
Panel	Kai Huat Lam, Chi Young Shim, Sung Kee Ryu, Hae-Young Lee
10:45-10:55	Overview of Cardiac Rehabilitation	Melissa Tracy / Rush Univ., USA
10:55-11:05	Cardiac Rehabilitation during the COVID Pandemic	Alison Bailey / HCA Healthcare, USA
11:05-11:15	Does Telerehabilitation Work?	Seok Min Kang / Yonsei Univ., Korea
11:15-11:30	Discussion

[ACC Together with KSC/KHRS 4]		Apr. 16 (Sat.) 09:50-10:35 Rm.105
New Pacing Strategies: Leadless, His Bundle
Chairperson(s)	Fred Kusumoto, Sang Weon Park
Panel	Il-Young Oh
09:50-10:00	Leadless Pacing	Seung Jung Park / Sungkyunkwan Univ., Korea
10:00-10:10	Conduction Tissue Pacing	Win-Kuang Shen / Mayo Clinic, USA
10:10-10:20	Future of Pacing	Yong-Mei Cha / Mayo Clinic, USA
10:20-10:35	Discussion

[ACC Together with KSC/KHRS 5]		Apr. 16 (Sat.) 10:45-11:30 Rm.105
What Will Be New in 2025: Pulsed Field Ablation, Cardioneuroablation?
Chairperson(s)	Charles Jia-Yin Hou, Seil Oh
Panel	Jaemin Shim, Jae-Sun Uhm
10:45-10:55	New Technologies for Ablation	Anca Chiriac / Mayo Clinic, USA
10:55-11:05	New Ablation Targets: Focus on Cardioneuroablation	Rakesh Gopinathannair / Kansas City Heart Rhythm Institute, USA
11:05-11:15	New Devices for HF	Jagmeet Singh / Harvard Medical School, USA
11:15-11:30	Discussion

[Hypertension]		Apr. 16 (Sat.) 09:50-10:35 Rm.205
Obesity and Hypertension
Chairperson(s)	Ki Chul Sung, Hyeong Kyu Park
Panel	Hae-Young Lee, Eun Joo Cho
09:50-10:05	Obesity and Hypertension: Pathophysiologic Link	Rhee Sang Youl / Kyunghee Univ., Korea
10:05-10:20	Management of Obesity: Beyond Life Style Modifications
10:20-10:35	Discussion

[Vascular]		Apr. 16 (Sat.) 10:45-11:30 Rm.205
Vascular Health and Cardiac Rehabilitation (Endurance or High-intensity Interval Exercise?)
Chairperson(s)	Jin-Ok Jeong, Jang-Young Kim
Panel	Jin Sun Park, Chan Joo Lee, Young-Hyo Lim, Eun Joo Cho
10:45-10:57	Endurance Exercise: Mostly Good but a Few Concerns	Kee Chan Joo / ACSM Representative in Korea
10:57-11:09	High Intensity Interval Training for Patients with Cardiovascular Disease - Is It Safe?	Se Young Jae / 서울시립대학교, Korea
11:09-11:14	Endurance Exercise (Rebuttal)	Kee Chan Joo / ACSM Representative in Korea
11:14-11:19	High Intensity Interval Training (Rebuttal)	Se Young Jae / 서울시립대학교, Korea
11:19-11:30	Discussion

[Scientific Session [Viatris]]		Apr. 16 (Sat.) 11:40-12:20 Rm.300C
Stepwise Treatment Options for Dyslipidemia
Chairperson(s)	Byung Ryul Cho, Tae Hyun Yang
11:40-12:10	Individual Lipid Management Selecting the Optimal Drug for the Right Patient	Kausik Ray / Imperial College NHS Trust, UK
12:10-12:20	Discussion

[Scientific Session [Amgen]]		Apr. 16 (Sat.) 11:40-12:20 Rm.102
Guideline-directed Lipid Lowering Therapy for ACS Patients
Chairperson(s)	Jang-Whan Bae, Byeong-Keuk Kim
Panel	Myung Soo Park, Jun Hyuk Oh
11:40-11:55	Guideline-based Strategy in Lipid Treatment Optimization After ACS: When to Check?	Min Chul Kim / Chonnam National Univ., Korea
11:55-12:10	Clinical Differentiation of Evolocumab in LDL-C Management	Won Jae Lee / Seoul National Univ., Korea
12:10-12:20	Discussion

[Scientific Session [Hanmi]]		Apr. 16 (Sat.) 11:40-12:20 Rm.103
Strategies for Atherosclerosis Prevention in Dyslipidemia Patients with Hypertension
Chairperson(s)	Hyo-Soo Kim, Cheol Whan Lee
11:40-12:00	The Recent Trend of Hypertension Management Focused on Intensive & Comorbid Treatment	Hancheol Lee / Pusan National Univ., Korea
12:00-12:20	Why Should We Consider Rosuvastatin+Ezetimibe Combination	Weon Kim / Kyunghee Univ., Korea

[Scientific Session [Daiichisankyo/Daewoong]]		Apr. 16 (Sat.) 11:40-12:20 Rm.105
Update on Diagnosis and Treatment of High Risk Patients of Hypertension and AF
Chairperson(s)	Hui Nam Pak, Sang Hyun Ihm
11:40-12:00	Update on Evidence-based Management of High Risk Patients with Hypertension	Hae-Young Lee / Seoul National Univ., Korea
12:00-12:20	Update on NOAC Management of Very High-risk Patient with AF	Eue-Keun Choi / Seoul National Univ., Korea

[Scientific Session [Yuhan]]		Apr. 16 (Sat.) 11:40-12:20 Rm.203
A.I-based Wearable Electrocardiography
Chairperson(s)	Young-Hoon Kim
11:40-12:20	Holter vs. Wearable Patch for Arrhythmia Evaluation	Il-Young Oh / Seoul National Univ., Korea

[Scientific Session [JW－Pharma]]		Apr. 16 (Sat.) 11:40-12:20 Rm.205
Optimal Management of Dislipidemia: Newest Evidence from Pitavastatin and Ezetimibe
Chairperson(s)	Kee Sik Kim, Kyoo Rok Han
11:40-12:00	Are Statins All the Same in Outcome and Safety for Asian?	Seong Hwan Lee / Ulsan Univ., Korea
12:00-12:20	Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy	Jong-Young Lee / Sungkyunkwan Univ., Korea

[Plenary Lecture]		Apr. 16 (Sat.) 12:30-13:15 Rm.300C
Chairperson(s)	Dipti Itchhaporia, Myeong-Chan Cho
12:30-13:15	Interventional Therapy: What’s Next	Roxana Mehran / Mount Sinai, USA

[Cardiac Pathology]		Apr. 16 (Sat.) 13:20-14:50 Rm.103
Myocarditis in COVID-19 Pandemic
Chairperson(s)	Jeong Wook Seo
Panel	Lucy Youngmin Eun, Sang Han Lee, Seulgi Cha
13:20-13:40	Pathology of Myocarditis	Jung Sun Kim / Sungkyunkwan Univ., Korea
13:40-14:00	COVID-19 Myocarditis, Clinical Spectrum	In-Cheol Kim / Keimyung Univ., Korea
14:00-14:20	COVID-19 Myocarditis, Pathologic Spectrum	Ji Won Koh / Seoul National Univ., Korea
14:20-14:40	A Clinician's Approach and Management of Myocarditis	Jee Hoon Kang / Seoul National Univ., Korea
14:40-14:50	Discussion

[Cardio - Oncology]		Apr. 16 (Sat.) 13:20-14:50 Rm.203
Immunotherapy and Emerging Cardiotoxicity
Chairperson(s)	Il Suk Sohn, Yun Gyoo Lee
Panel	Hak Jin Kim, Chan Seok Park, Woo-Baek Chung
13:20-13:40	Monoclonal Antibody and Cardiotoxicty for Cardiologists	Jamin Byun / Seoul National Univ., Korea
13:40-14:00	CAR-T and Potential Cardiotoxicity for Cardiologists
14:00-14:20	Immune Check Point Inhibitor and Cardiotoxicity for Cardiologists
14:20-14:40	Immnunotherapy Related Cardiotoxicity: Cardiologist's View	Eun Kyoung Kim / Sungkyunkwan Univ., Korea
14:40-14:50	Discussion

[Cardiac Surgery]		Apr. 16 (Sat.) 13:20-14:50 Rm.205
Optimal Revascularization Strategy of CABG
Chairperson(s)	Hyun Keun Jee, Young-Nam Youn
Panel	Do-Yoon Kang, Suk Ho Sohn, Kyo Seon LEE
13:20-13:40	Discrepancy in FFR-guided PCI and FFR-guided CABG	Chang Wook Nam / Keimyung Univ., Korea
13:40-14:00	Current Evidence of Functional Ischemia-based CABG	Ho Young Hwang / Seoul National Univ., Korea
14:00-14:20	Total Arterial Revascularization Using Right ITA	Gijong Yi / Yonsei Univ., Korea
14:20-14:50	Discussion

[Education Workshop 5]		Apr. 16 (Sat.) 15:00-16:30 Rm.300C
Updates in Atrial Fibrillation Diagnosis and Management
Chairperson(s)	Nam Ho Kim, YoungKeun On
Panel	ji hyun Lee, Jong Min Hwang
15:00-15:15	심방세동 기전 및 위험인자 관리	Ki Hong Lee / Chonnam National Univ., Korea
15:15-15:30	심방세동 스크리닝과 진단	Woo-Hyun Lim / Seoul National Univ., Korea
15:30-15:45	심방세동 뇌졸중 예방을 위한 항응고 최신 지견	Jong Sung Park / Dong-A Univ., Korea
15:45-16:00	항부정맥약제를 이용한 심방세동 약물 치료	Jaemin Shim / Korea Univ., Korea
16:00-16:15	심방세동 도자절제술을 이용한 리듬 조절 전략	Jae-Sun Uhm / Yonsei Univ., Korea
16:15-16:30	Discussion

[Education Workshop 6]		Apr. 16 (Sat.) 16:40-18:10 Rm.300C
Take a First Step for TAVR
Chairperson(s)	Young-Guk Ko, Seung-Hyuk Choi
Panel	HyungDon Kook, Jeongsu Kim, Hoyoun Won, Han Young JIN
16:40-16:55	Pre-Procedural Planning for TAVR	Juhan Kim / Chonnam National Univ., Korea
16:55-17:10	Decision for Balloon-expandable vs Self-expandable Valve in TAVR	Jung-Hee Lee / Yonsei Wonju Univ., Korea
17:10-17:25	Step-by-step TAVR Procedure	Duk Woo Park / Ulsan Univ., Korea
17:25-17:40	TAVR for Young and/or Low Risk Patients	Ung Kim / Yeungnam Univ., Korea
17:40-17:55	Optimal Antithrombotic Treatment after TAVR	Byung-Hee Hwang / Catholic Univ., Korea
17:55-18:10	Discussion

[abstract test]		Apr. 16 (Sat.) 12:30-13:15 Rm.102
12:30-12:35
12:35-12:40
12:40-12:45